Loading...
OTCM
MDRX
Market cap808mUSD
Jul 09, Last price  
4.75USD
1D
-0.21%
1Q
5.56%
Jan 2017
-53.48%
Name

Veradigm Inc

Chart & Performance

D1W1MN
OTCM:MDRX chart
P/E
P/S
1.37
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
5.03%
Revenues
588m
+1.83%
85,841,000100,770,000120,564,000227,969,000281,908,000548,439,000704,502,000704,502,0001,444,077,0001,446,325,0001,373,061,0001,377,873,0001,386,393,0001,549,899,0001,497,708,0001,749,962,0001,632,611,0001,502,700,000577,427,000588,017,000
Net income
-86m
L
-4,979,0003,108,0009,710,00011,895,00020,563,00026,022,00062,870,000144,202,00073,609,000-33,767,000-104,026,000-66,453,000-2,226,000-25,652,000-196,459,000363,740,000-182,178,000700,407,000134,438,000-86,462,000
CFO
116m
P
12,447,00016,507,00027,413,00030,517,00036,077,000139,918,000139,900,000139,900,000268,754,000222,670,00080,987,000103,496,000211,579,000269,004,000279,415,00067,891,00046,254,000-106,715,000-75,428,000115,562,000
Dividend
Oct 13, 20085.23 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform. The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency. Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology. The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.
IPO date
Jul 23, 1999
Employees
8,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT